Definium Therapeutics DFTX
NASDAQ DFTX
$38.41 +2.24 (+6.19%)
At close: Sep 28, 2026 · 4:00 PM EDT

Definium Therapeutics (DFTX) Common Equity (2020 - 2026)

Updated

Definium Therapeutics' Common Equity was $918.68 million in Q2 2026, up 395.5% from $185.4 million a year earlier and up 229.5% from the prior quarter.

Analysis

Definium Therapeutics (DFTX) Common Equity (2020 - 2026) Analysis & Trends

At the end of FY2025, Common Equity at Definium Therapeutics came in at $332.33 million, up 37.6% from FY2024.

  • Common Equity shows a five-year compound annual growth rate of 34.4% (FY2020 to FY2025).
  • In earlier years, Common Equity was $241.45 million in FY2024 (+209.0%), $78.13 million in FY2023 (-48.2%), $150.92 million in FY2022 (-0.5%) and $151.66 million in FY2021 (+99.9%).
  • The Q2 2026 figure marks the highest quarterly Common Equity in data going back to Q4 2020.
  • Compared with a year earlier, Common Equity has increased for three straight quarters, with growth averaging 99.5% over the last eight quarters.
  • The best year-over-year quarter for Common Equity over five years was Q2 2026 (growth of 395.5%); the worst was Q3 2025 (a decline of 50.2%).
  • Per Business Quant data, DFTX's Common Equity in the three quarters before Q2 2026 was $278.85 million (Q1 2026), $332.33 million (Q4 2025) and $130.6 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 84.97 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn -5.94 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn 50.37 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 20.25 Bn
10 Definium Therapeutics 4.00 Bn 4.00 Bn - 918.68 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 918.68 Mn
Mar 31, 2026 278.85 Mn
Dec 31, 2025 332.33 Mn
Sep 30, 2025 130.60 Mn
Jun 30, 2025 185.40 Mn
Mar 31, 2025 222.81 Mn
Dec 31, 2024 241.45 Mn
Sep 30, 2024 262.19 Mn
Jun 30, 2024 202.05 Mn
Mar 31, 2024 196.06 Mn
Dec 31, 2023 78.13 Mn
Sep 30, 2023 95.98 Mn
Jun 30, 2023 105.97 Mn
Mar 31, 2023 130.34 Mn
Dec 31, 2022 150.92 Mn
Sep 30, 2022 153.59 Mn
Jun 30, 2022 124.50 Mn
Mar 31, 2022 136.81 Mn
Dec 31, 2021 151.66 Mn
Sep 30, 2021 164.27 Mn
API Access

Definium Therapeutics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=DFTX&period=max&api_key=YOUR_API_KEY